Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study to collect information on the safety, especially localized
injection site reactions, and efficacy of ORENCIA Subcutaneous Injection 125mg Syringe 1mL in
patients with rheumatoid arthritis.